Rademikibart IV for Acute Asthma and COPD Exacerbation

NCT07705737 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma Acute
COPD Exacerbation Acute

Interventions

DRUG: Rademikibart

Sponsor

Connect Biopharm LLC